Search Results - "Gora Tybor, Joanna"

Personality traits favourable for non-adherence to treatment in patients with chronic myeloid leukaemia: role of type A and D personality by Rychter, Anna, Miniszewska, Joanna, Góra-Tybor, Joanna

“…The introduction of BCR-ABL tyrosine kinase inhibitors (TKIs) to chronic myeloid leukemia (CML) therapy has revolutionized the treatment of this disease…”
Get full text

Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci? by Macauda, Angelica, Giaccherini, Matteo, Sainz, Juan, Gemignani, Federica, Sgherza, Nicola, Sánchez‐Maldonado, José Manuel, Gora‐Tybor, Joanna, Martinez‐Lopez, Joaquin, Carreño‐Tarragona, Gonzalo, Jerez, Andrés, Spadano, Raffaele, Gołos, Aleksandra, Jurado, Manuel, Hernández‐Mohedo, Francisca, Mazur, Grzegorz, Tavano, Francesca, Butrym, Aleksandra, Várkonyi, Judit, Canzian, Federico, Campa, Daniele

“…Myeloproliferative neoplasms (MPNs) are a group of diseases that cause myeloid hematopoietic cells to overproliferate. Epidemiological and familial studies…”
Get full text

Poor prognosis of Hodgkin variant of Richter transformation in chronic lymphocytic leukemia treated with cladribine by Jamroziak, Krzysztof, Grzybowska-Izydorczyk, Olga, Jesionek-Kupnicka, Dorota, Gora-Tybor, Joanna, Robak, Tadeusz

Get full text

Targeted drugs in chronic myeloid leukemia by Gora-Tybor, Joanna, Robak, Tadeusz

“…Chronic myeloid leukemia (CML) is characterized by the presence of the Philadelphia (Ph) chromosome, which results from a reciprocal translocation between the…”
Get more information

Azacitidine for relapse of acute myeloid leukemia or myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation, multicenter PALG analysis by Drozd‐Sokołowska, Joanna, Karakulska‐Prystupiuk, Ewa, Biecek, Przemysław, Kobylińska, Katarzyna, Piekarska, Agnieszka, Dutka, Magdalena, Waszczuk‐Gajda, Anna, Mądry, Krzysztof, Kopińska, Anna, Gołos, Aleksandra, Góra‐Tybor, Joanna, Szwedyk, Paweł, Bołkun, Łukasz, Czyż, Anna, Giebel, Sebastian, Basak, Grzegorz Władysław, Dwilewicz‐Trojaczek, Jadwiga

“…Objectives Relapse of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo‐HSCT)…”
Get full text

Comparison of Cladribine Plus Cyclophosphamide With Fludarabine Plus Cyclophosphamide As First-Line Therapy for Chronic Lymphocytic Leukemia: A Phase III Randomized Study by the Polish Adult Leukemia Group (PALG-CLL3 Study) by Robak, Tadeusz, Jamroziak, Krzysztof, Gora-Tybor, Joanna, Stella-Holowiecka, Beata, Konopka, Lech, Ceglarek, Bernadetta, Warzocha, Krzysztof, Seferynska, Ilona, Piszcz, Jaroslaw, Calbecka, Malgorzata, Kostyra, Aleksandra, Dwilewicz-Trojaczek, Jadwiga, Dmoszyñska, Anna, Zawilska, Krystyna, Hellmann, Andrzej, Zdunczyk, Andrzej, Potoczek, Stanislaw, Piotrowska, Magdalena, Lewandowski, Krzysztof, Blonski, Jerzy Z

“…PURPOSE Little is known about comparison of the activity of different purine nucleoside analogs in chronic lymphocytic leukemia (CLL). We conducted a…”
Get full text

Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia by Madejczyk, Anna Marta, Canzian, Federico, Góra-Tybor, Joanna, Campa, Daniele, Sacha, Tomasz, Link-Lenczowska, Dorota, Florek, Izabela, Prejzner, Witold, Całbecka, M, Rymko, M, Dudziński, M, Orzechowska, Magdalena Julita, Jamroziak, Krzysztof

“…Functional single-nucleotide polymorphisms (SNPs) in genes regulating cellular uptake, elimination, and metabolism of xenobiotics may potentially influence the…”
Get full text

Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs by Sobas, Marta, Kiladjian, Jean-Jacques, Beauverd, Yan, Curto-Garcia, Natalia, Sadjadian, Parvis, Shih, Lee Yung, Devos, Timothy, Krochmalczyk, Dorota, Galli, Serena, Bieniaszewska, Maria, Seferynska, Ilona, McMullin, Mary Frances, Armatys, Anna, Spalek, Adrianna, Waclaw, Joanna, Zdrenghea, Mihnea, Legros, Laurence, Girodon, François, Lewandowski, Krzysztof, Angona Figueras, Anna, Samuelsson, Jan, Abuin Blanco, Aitor, Cony-Makhoul, Pascale, Collins, Angela, James, Chloé, Kusec, Rajko, Lauermannova, Marie, Noya, Maria Sol, Skowronek, Malgorzata, Szukalski, Lukasz, Szmigielska-Kaplon, Anna, Wondergem, Marielle, Dudchenko, Iryna, Gora Tybor, Joanna, Laribi, Kamel, Kulikowska de Nalecz, Anna, Demory, Jean-Loup, Le Du, Katell, Zweegman, Sonja, Besses Raebel, Carlos, Skoda, Radek, Giraudier, Stéphane, Griesshammer, Martin, Harrison, Claire N., Ianotto, Jean-Christophe

“…Myeloproliferative neoplasms (MPNs) are uncommon in children/young adults. Here, we present data on unselected patients diagnosed before 25 years of age…”
Get full text

A multicenter prospective study on efficacy and safety of imatinib generics: A report from Polish Adult Leukemia Group imatinib generics registry by Sacha, Tomasz, Góra‐Tybor, Joanna, Szarejko, Monika, Bober, Grażyna, Grzybowska‐Izydorczyk, Olga, Niesiobędzka‐Krężel, Joanna, Dudziński, Marek, Wasilewska, Ewa, Myśliwiec, Krzysztof, Gil, Justyna, Gniot, Michał, Pietkun, Iwona, Mędraś, Ewa, Hołojda, Jadwiga, Wącław, Joanna, Giannopoulos, Krzysztof

Get full text

Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms by Giaccherini, Matteo, Macauda, Angelica, Sgherza, Nicola, Sainz, Juan, Gemignani, Federica, Maldonado, Josè Manuel Sanchez, Jurado, Manuel, Tavano, Francesca, Mazur, Grzegorz, Jerez, Andrés, Góra-Tybor, Joanna, Gołos, Aleksandra, Mohedo, Francisca Hernández, Lopez, Joaquin Martinez, Várkonyi, Judit, Spadano, Raffaele, Butrym, Aleksandra, Canzian, Federico, Campa, Daniele

“…Telomere length measured in leukocyte (LTL) has been found to be associated with the risk of developing several cancer types, including myeloproliferative…”
Get full text

The Influence of Maltotriose-Modified Poly(propylene imine) Dendrimers on the Chronic Lymphocytic Leukemia Cells in Vitro: Dense Shell G4 PPI by Franiak-Pietryga, Ida, Ziółkowska, Ewelina, Ziemba, Barbara, Appelhans, Dietmar, Voit, Brigitte, Szewczyk, Michał, Góra-Tybor, Joanna, Robak, Tadeusz, Klajnert, Barbara, Bryszewska, Maria

“…Chronic lymphocytic leukemia (CLL) is the most common leukemia in Europe and North America. For many years scientists and doctors have been working on…”
Get full text

Primary pulmonary Hodgkin’s lymphoma mimicking granulomatosis with polyangiitis – a case report of diagnostic and therapeutic dilemmas by Sławiński, Lucjan, Sołek, Julia Maria, Miłkowska-Dymanowska, Joanna, Jesionek-Kupnicka, Dorota, Góra-Tybor, Joanna, Mikulski, Damian, Braun, Marcin

“…Primary pulmonary Hodgkin’s lymphoma (PPHL) is a rare subtype of lymphoma that comprises a small percentage of primary pulmonary lymphomas. Due to its rarity…”
Get full text

Activity of Cladribine Combined With Cyclophosphamide in Frontline Therapy for Chronic Lymphocytic Leukemia With 17p13.1/ TP53 Deletion : Report From the Polish Adult Leukemia Group by ROBAK, Tadeusz, BLONSKI, Jerzy Z, WAWRZYNIAK, Ewa, GORA-TYBOR, Joanna, PALACZ, Aleksandra, DMOSZYNSKA, Anna, KONOPKA, Lech, WARZOCHA, Krzysztof, JAMROZIAK, Krzysztof

“…The 17p13.1 deletion that causes loss of the p53-encoding TP53 gene is the most powerful predictor of a poor response to conventional therapy and shortened…”
Get full text

The Presence of Typical and Atypical BCR-ABL Fusion Genes in Leukocytes of Normal Individuals: Biologic Significance and Implications for the Assessment of Minimal Residual Disease by Bose, Shikha, Deininger, Michael, Gora-Tybor, Joanna, Goldman, John M., Melo, Junia V.

“…The number of genetic lesions necessary to generate leukemia in humans is unknown, but it is possible that certain specific abnormalities, eg, fusion genes,…”
Get full text

Experimental drugs in clinical trials for acute myeloid leukemia: innovations, trends, and opportunities by Gołos, Aleksandra, Góra-Tybor, Joanna, Robak, Tadeusz

“…Acute myeloid leukemia (AML) is a heterogeneous disease characterized by many cytogenetic and molecular alterations. Due to better knowledge of the molecular…”
Get more information

Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil - follow-up of PALG-CLL randomized trials by Blonski, Jerzy Z., Robak, Tadeusz, Chojnowski, Krzysztof, Gora-Tybor, Joanna, Warzocha, Krzysztof, Ceglarek, Bernadetta, Seferynska, Ilona, Calbecka, Malgorzata, Kostyra, Aleksandra, Stella-Holowiecka, Beata, Kloczko, Janusz, Dmoszynska, Anna, Kowal, Malgorzata, Lewandowski, Krzysztof, Dwilewicz-Trojaczek, Jadwiga, Wiater, Elzbieta, Kuliczkowski, Kazimierz, Potoczek, Stanislaw, Hellmann, Andrzej, Mital, Andrzej, Skotnicki, Aleksander, Nowak, Wieslaw, Sulek, Kazimierz, Zawilska, Krystyna, Trelinski, Jacek

“…Objectives The relationship between treatments of chronic lymphocytic leukemia (CLL) with cladribine (2‐CdA) or chlorambucil and immune thrombocytopenia (IT)…”
Get full text

Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion by Robak, Tadeusz, Blonski, Jerzy Z., Wawrzyniak, Ewa, Gora‐Tybor, Joanna, Palacz, Aleksandra, Dmoszynska, Anna, Konopka, Lech, Warzocha, Krzysztof, Jamroziak, Krzysztof

“…BACKGROUD: The 17p13.1 deletion that causes loss of the p53‐encoding TP53 gene is the most powerful predictor of a poor response to conventional therapy and…”
Get full text

Real-World Outcome and Prognostic Factors in MDS Patients Treated with Azacitidine-A Retrospective Analysis by Wiśniewski, Kamil, Pruszczyk-Matusiak, Katarzyna, Puła, Bartosz, Lech-Marańda, Ewa, Góra-Tybor, Joanna

“…Azacitidine (AZA) is recognized as a vital drug used in the therapy of myelodysplastic syndromes (MDS) due to its beneficial effect on survival and quality of…”
Get full text

Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia by Gora-Tybor, Joanna, Blonski, Jerzy Z, Robak, Tadeusz

“…The serum concentration of two pro-angiogenic cytokines: basic fibroblast growth factor (bFGF) and transforming growth factor beta1 (TGF-β1), and…”
Get full text

Risk Factors of Infection in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone (Rd) Regimen: Real-Life Results of a Large Single-Center Study by Mikulski, Damian, Robak, Paweł, Ryżewska, Wiktoria, Stańczak, Kamila, Kościelny, Kacper, Góra-Tybor, Joanna, Robak, Tadeusz

“…Lenalidomide-based regimens are effective treatment options for patients with relapsed/refractory multiple myeloma (RRMM). However, they are associated with an…”
Get full text